The radiologist who stopped reading scans - and started writing the AI that reads them
He trained to read brains. Then he turned to teaching machines to read everything else. Now Dr. Eduardo Reis is VP Strategy at Hippocratic AI, the generative AI company building patient-facing agents for a world that can't hire enough clinicians.
Most doctors pick a lane. Eduardo Pontes Reis, MD picked all of them simultaneously. A trained neuroradiologist from Brazil with a fellowship at Hospital Israelita Albert Einstein - one of Latin America's foremost medical institutions - he arrived at Stanford's Center for Artificial Intelligence in Medicine and Imaging (AIMI) not as a passenger but as a builder. Within a couple of years, he had published datasets in Nature, open-sourced machine learning models, helped spin out a startup, and watched it sell for eight figures. In early 2026, he joined Hippocratic AI as Vice President of Strategy in the Office of the CEO, arriving at a company that has raised $439 million to put patient-facing AI agents into health systems, payer organizations, and life sciences companies worldwide.
What separates Reis from the typical "physician-turned-tech" narrative is the absence of a clean conversion moment. He never left medicine to do AI. He made them occupy the same room, argue with each other, and eventually ship something useful. The BRAX dataset he co-authored at Hospital Israelita Albert Einstein contains 40,967 labeled chest X-ray images - scans from real Brazilian patients - and became a public resource for training AI models in settings where English-language data doesn't translate. The labels were derived using NLP from radiology reports written in Portuguese. The research crossed language barriers, geographic barriers, and the traditional boundary between clinician and engineer.
"Deep expertise at the intersection of clinical medicine, medical imaging, and artificial intelligence."
- Hippocratic AI press release, February 2026, on appointing Eduardo Reis as VP StrategyThat intersection is exactly what Hippocratic AI needs. The company's platform - built around patient-facing conversational AI agents - requires someone who understands both the clinical stakes of a wrong answer and the technical architecture required to prevent one. Reis brings both. At Albert Einstein in Brazil, he led AI development for diseases of national significance: tuberculosis, COVID-19, melanoma, and head CT analysis. He didn't just study these applications - he built them, evaluated them in clinical settings, and thought hard about what happens when they fail.
His open-source footprint tells a parallel story. On GitHub under the handle edreisMD, Reis has 49 repositories and contributions to high-profile projects including LangChain and Open-Assistant. He built plugnplai, a Python library for integrating AI plugins into large language models, before plugin ecosystems became fashionable. He built Comp2Comp, converting CT scans into body composition analysis - a tool with 115 stars and real clinical utility. He earned GitHub's "YOLO" badge, which requires merging a pull request without a code review. A neuroradiologist. Who YOLOs merges. That's the contradiction at the center of Eduardo Reis.
Between Stanford and Hippocratic AI, Reis served as Founding Radiologist at Cognita Imaging, an AI startup that spun out of Stanford's AIMI lab. Cognita developed vision language models for analyzing CT and X-ray images and drafting initial radiology reports - a direct commercial application of the research Reis had been doing for years. The company operated in stealth. Then, in November 2025, Radiology Partners acquired it for approximately $80 million. Three months later, Reis was announced as VP Strategy at Hippocratic AI, joining alongside a new Associate Chief Medical Officer and Chief Marketing Officer as the company scales following its $141 million Series C.
The Health Story project at Hospital Israelita Albert Einstein is worth pausing on. Reis initiated it - a medical timeline system designed to support clinical research and personalized patient care. The idea was deceptively simple: stitch together a patient's entire medical history into a coherent, structured timeline that clinicians and systems could navigate. In practice, it required pulling data from scattered sources, normalizing it across formats, and making it legible both to human readers and to algorithms.
That's the throughline in Reis's career: he works on problems that require bridging the gap between the messiness of clinical data and the cleanliness required for AI systems. The BRAX dataset - 24,959 studies, 14 labels, derived from Portuguese-language reports using NLP - was exactly that kind of project. So was the Brain Hemorrhage Extended (BHX) dataset he released on PhysioNet. So was ConVIRT-pytorch, his implementation of a contrastive learning method for radiology images and text. Each project made something real and clinical usable by the broader AI research community.
At Hippocratic AI, the challenge is different in scale but similar in structure. The company's agents don't diagnose - they communicate. They do chronic care management, patient education, medication adherence follow-up, and pre-appointment preparation. They're non-diagnostic by design, and that constraint is a feature, not a limitation: it's what allows them to operate at scale without running into the regulatory wall that stops diagnostic AI cold.
Reis's role as VP Strategy in the Office of the CEO puts him at the center of how the company decides where to grow. After $439 million in total funding and a customer base spanning providers, payers, and life sciences organizations, the strategic questions are no longer "can we build this?" They're "where do we deploy this next, and how do we make sure it's safe when we get there?"
Clinical safety isn't a checkbox at Hippocratic AI - it's the product. The company's Polaris constellation architecture was built specifically to layer multiple safety checks into every patient interaction. Reis's background in building and evaluating AI systems for real-world clinical use - at institutions where the consequences of failure are measured in patient outcomes, not product metrics - is exactly the lens that strategic decisions at this stage require.
He also brings something less common among healthcare AI executives: genuine open-source credibility. His contributions to LangChain and Open-Assistant, and his own repositories on GitHub, signal a style of working that values transparency, reproducibility, and community over proprietary secrecy. In a field where clinical validation is everything, the instinct to build in public and let the work be tested is a competitive advantage.
While most radiologists were still reading films, Eduardo Reis was building the dataset that would train the next generation of AI readers. The BRAX project turned 40,000+ de-identified Brazilian chest X-rays into one of the largest publicly available labeled chest radiology datasets in the world. The labels were derived using NLP from reports written in Brazilian Portuguese - a deliberate choice that addressed a real gap in medical AI, where English-language training data dominates and performance degrades when deployed in other languages and healthcare systems.
Before joining Hippocratic AI, Reis built plugnplai - a tool to help developers plug external AI capabilities into large language models. He built it on GitHub in public, earned 228 stars, and moved on. The project foreshadowed his trajectory from pure research to enabling AI systems that work in the real world, connecting models to tools and contexts they weren't originally trained on. He was solving the plugin integration problem before OpenAI launched its plugin store.
Cognita Imaging, the Stanford AIMI spinoff where Reis served as Founding Radiologist, ran in stealth mode. The company developed vision language models for analyzing CT and X-ray images and generating initial radiology reports - a more versatile approach than the point-source AI models that dominated radiology AI at the time. Radiology Partners acquired it for approximately $80 million in November 2025, citing clinical results showing a 52% increase in detection rates and a 76% reduction in reading times. Three months later, Reis joined Hippocratic AI.